A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)

NCT04107961 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The trial will be undertaken but the protocol will be substantially revised.

Conditions

Interventions

Sponsor

University of York

Collaborators